CLINICAL_TRIALS
trial_result
· 2024-05-29
Clinical Trial Update: Real World Effectiveness of Eptinezumab in Participants With Migraine [Phase 4]
Summary
Phase 4 real-world effectiveness study of eptinezumab for migraine; the trial was terminated and results were posted in May 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Migraine | Phase 4 | Status: TERMINATED | Results posted: 2024-05-29